Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05208190 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

Study acronym: REVISIT-C
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description shortened, about 83 wordsv12
  2. Primary completion date: Jan 23, 2027 to Jun 30, 2028
    • Study completion date: Feb 28, 2027 to Dec 31, 2028
    v11
  3. Site details revised at 1 of 7 sitesv10
  4. Primary completion date: Jun 30, 2028 to Jan 23, 2027
    • Study completion date: Dec 31, 2028 to Feb 28, 2027
    v9
  5. Primary completion date: Jan 23, 2027 to Jun 30, 2028
    • Study completion date: Feb 28, 2027 to Dec 31, 2028
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Study description expanded, about 83 wordsv7
  2. Site details revised at 7 of 7 sitesv6
  3. 2 versions Re-verified since Mar 27, 2023, no change to tracked fieldsv4-v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 26, 2022 to Mar 17, 2022
    • Site details revised at 7 of 7 sites
    v3
  5. Start date: Jan 26, 2022 to Feb 26, 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Two-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm, parallel-group, 24-week, open-label, 7-site clinical trial to examine the effects of treatment with clozapine vs antipsychotic treatment as usual (TAU) for reducing the risk of violent acts in real-world settings
Trial Details
NCT Number NCT05208190
Lead Sponsor New York State Psychiatric Institute
Collaborators: National Institute of Mental Health (NIMH)
Conditions
(from sponsor)		 Schizophrenia, Schizoaffective Disorder
Related terms Psychotic Disorders, Schizophrenia
Enrollment 280 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov